(19)
(11) EP 4 543 458 A1

(12)

(43) Date of publication:
30.04.2025 Bulletin 2025/18

(21) Application number: 22949607.0

(22) Date of filing: 22.06.2022
(51) International Patent Classification (IPC): 
A61K 31/56(2006.01)
A61K 31/00(2006.01)
A61K 9/00(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 31/565
(86) International application number:
PCT/US2022/034463
(87) International publication number:
WO 2024/005770 (04.01.2024 Gazette 2024/01)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(71) Applicant: Lipocine Inc.
Salt Lake City, UT 84108 (US)

(72) Inventors:
  • KIM, Kilyoung
    Salt Lake City, UT 84108 (US)
  • PATEL, Mahesh, V.
    Salt Lake City, UT 84108 (US)
  • CHIDAMBARAM, Nachiappan
    Salt Lake City, UT 84108 (US)
  • FRANK, Joel
    Salt Lake City, UT 84108 (US)

(74) Representative: Vossius & Partner Patentanwälte Rechtsanwälte mbB 
Siebertstraße 3
81675 München
81675 München (DE)

   


(54) (17-)-3-OXOANDROST-4-EN-17-YL DODECANOATE COMPOSITIONS AND METHODS OF PREPARATION AND USE